Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

Veradermics Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One increased by 153.7% to $289.30M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryLiquidity

SignalHigher is better

VolatilityStable

First reportedQ4 2025

Last reportedQ1 2026

How to read this metric

Higher values indicate greater near-term liquidity, allowing the company to reinvest or fund operations without selling assets.

Detailed definition

This metric tracks the fair value of debt securities in the available-for-sale portfolio that are scheduled to mature wi...

Peer comparison

Standard maturity profile disclosure for utilities with structured investment portfolios.

Metric ID: other_available_for_sale_securities_debt_maturities_with_de2040

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$114.05M	$289.30M
QoQ Change	—	+153.7%

Range$114.05M – $289.30M

Frequently Asked Questions

What is Veradermics 's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one?: Veradermics (MANE) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one of $289.30M in Q1 2026.
What does debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one mean?: The value of debt investments that will mature and return cash within the next year.